Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

MICHIGAN: HIV Sufferers Need Hepatitis Safeguards


Medical Xpress (03.27.13) Aids Weekly Plus

Michigan State University (MSU) researchers report the need for stronger protections—vaccination for hepatitis B and additional blood transfusion safeguards—to prevent hepatitis coinfection for HIV-infected people. Based on a review of all registered Michigan HIV cases, lead researcher Zahid Butt stated that approximately four percent of HIV-infected people were coinfected with hepatitis. Butt asserted that the prevalence of HIV and hepatitis B and C coinfection in Michigan was higher than expected, given the existing blood screening protocols. According to CDC, HIV infection “more than triples” the risk of death from liver disease and liver failure for people with hepatitis C. Hepatitis B and C attack the liver; untreated hepatitis infections can be fatal. In contrast to earlier studies that indicated African-American males have higher coinfection rates, the MSU study found males who marked their race as “other” had the highest coinfection rates. Butt theorized the higher rates among this group were due to insufficient safeguards during blood transfusions and lack of hepatitis B vaccination. He suggested the high coinfection cohort might have originated in countries that do not require childhood immunization for hepatitis B. Distrust of the healthcare system could also discourage people from hepatitis B immunization. To prevent future hepatitis infections among HIV-infected persons, Butt recommended “proper screening” of blood products used for transfusions and hepatitis vaccination for all HIV-infected individuals. The full report, “Hepatitis B and C Co-infection in HIV/AIDS Population in the State of Michigan,” was published online March 12, 2013, in the journal Epidemiology and Infection at


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in March 28, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.